Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |